Used as a key intermediate in the synthesis of fluorinated pharmaceutical compounds, particularly in the development of central nervous system (CNS) agents. Its structure supports the creation of bioactive molecules with enhanced metabolic stability and improved blood-brain barrier penetration. Commonly employed in medicinal chemistry for constructing pyridine-based scaffolds in drug discovery programs targeting neurological disorders and epilepsy. The difluoro moiety contributes to increased lipophilicity and resistance to oxidative degradation, making it valuable in optimizing pharmacokinetic properties of candidate drugs.